Halozyme withdraws Evotec acquisition proposal after biotech is ‘unwilling to engage’
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
When he started to notice a couple of things about himself that were “off,” Bobby Mukkamala, MD, president-elect of the American Medical Association (AMA), chalked
HOUSTON — Patients with melanoma brain metastases had better survival if they received radiotherapy (RT) followed by immunotherapy instead of the reverse sequence, a meta-analysis
Uptake of continuous glucose monitoring (CGM) was relatively low among vulnerable diabetes patients in the largest national system of safety-net primary care clinics, a retrospective
President-elect Donald Trump has chosen Marty Makary, MD, MPH, to run the FDA. Makary served as the editor-in-chief of MedPage Today from January 2020 through
Health officials on Friday confirmed bird flu in a California child — the first reported case in a U.S. minor. The child had mild symptoms,
A newly assembled FDA advisory committee recommended several approaches to how the agency should handle regulation of generative artificial intelligence (AI)-enabled medical devices during a